Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Concept Life Sciences announced key strategic appointments and advancements to further strengthen its services for the global pharmaceutical and biotechnology sectors.
read more
Meribel Pharma Solutions has launched with ten manufacturing sites and three drug development services sites, situated across France, Spain and Sweden, following the acquisition of CDMO, Synerlab Group and seven European manufacturing facilities from...
read more
PRISM BioLab, Co. has entered into a drug discovery collaboration with Elix, Inc. The partnership will accelerate research on small molecule inhibitors of protein-protein interaction (PPI) targets by combining PRISM BioLab's proprietary peptide ...
read more
Wednesday, April 09, 2025
Worldwide Clinical Trials has added a cutting-edge artificial intelligence (AI) tool to enhance clinical trial optimization. This new service segments patient populations to identify those most likely to drive a positive trial outcome, leading to ...
read more
Wednesday, April 09, 2025
PharmaLogic Holdings Corp. will acquire a majority stake in Agilera Pharma AS from the Institute for Energy Technology (IFE) in Norway, marking a significant step forward in the company's strategy to create the first fully-integrated, global CDMO ...
read more
Asahi Kasei has established Asahi Kasei Life Science, a new organizational structure dedicated to its bioprocess businesses. This move reflects the company’s commitment to addressing the evolving needs of the pharmaceutical industry by enhancing ...
read more
Clean Cells, part of the Clean Biologics group, announced the strategic acquisition of Karyologic Inc., a specialized karyotyping services company based in Durham, North Carolina, USA. This strategic acquisition marks a key milestone in Clean Cells’ ...
read more
Oncodesign Services has appointed Dr. Aidan Synnott as chief executive officer, to help strengthen its position as a trusted partner in drug discovery. The appointment reflects the company’s commitment to deepen client collaboration, enhance the ...
read more
Evestia Clinical, the new identity of EMAS Pharma, has launched as a provider of clinical research in oncology and rare diseases globally.
read more
CluePoints announced Usama Dar as its new Chief Product and Technology Officer. Having led both product and R&D teams through significant expansion, Usama is ideally placed to help CluePoints in the next phase of its growth journey.
read more
Kindeva has appointed Daniel J. Speciale as Chief Financial Officer (CFO) to strengthen its executive leadership team and drive financial strategy across the organization.
read more
George Clinical announced it has rebranded to become Emerald Clinical Trials. This strategic name change underscores the company's well-established position as a dedicated, reliable, consistent, and flexible CRO, while mitigating global clinical ...
read more
Curium Pharma, a provider of nuclear medicine services, announces the successful completion of its acquisition of Eczacibasi-Monrol Nuclear Products Co. (Monrol), a prominent player in nuclear medicine based in Istanbul, Turkey.
read more
Singota Solutions has opened a new 100,000 square-foot pharmaceutical storage and logistics facility in Balerna, Switzerland.
read more
Shanghai Henlius Biotech, Inc. and Organon announced that the European Medicines Agency (EMA) has validated the marketing authorization application (MAA) for HLX11, an investigational biosimilar of Perjeta® (pertuzumab). Pertuzumab has been approved ...
read more